Publications
- Pulmonary tularaemia in a female adolescent with inflammatory bowel disease receiving infliximab: Do not miss the diagnosis2023 | Second Faculty of Medicine, Faculty of Medicine in Pilsen
- Postvaccination Immunogenicity of BNT162b2 SARS-CoV-2 Vaccine and Its Predictors in Pediatric Inflammatory Bowel Disease2023 | Second Faculty of Medicine
- Safety of vedolizumab and ustekinumab in the treatment of pregnant women with inflammatory bowel disease - a multicentre retrospective-prospective observational study2022 | First Faculty of Medicine, Second Faculty of Medicine, Faculty of Medicine in Hradec Králové, Central Library of Charles University
- Safety of Ustekinumab and Vedolizumab During Pregnancy-Pregnancy, Neonatal, and Infant Outcome: A Prospective Multicentre Study2022 | First Faculty of Medicine, Second Faculty of Medicine, Faculty of Medicine in Hradec Králové, Central Library of Charles University
- Anti-SARS-CoV-2 Vaccination and Antibody Response in Patients With Inflammatory Bowel Disease on Immune-modifying Therapy: Prospective Single-Tertiary Study2022 | First Faculty of Medicine, Faculty of Physical Education and Sport, Second Faculty of Medicine
- Cellular and humoral immune responses to SARS-CoV-2 vaccination in inflammatory bowel disease patients2022 | First Faculty of Medicine, Second Faculty of Medicine
- Differences in the placental pharmacokinetics of vedolizumab and ustekinumab during pregnancy in women with inflammatory bowel disease: a prospective multicentre study2021 | First Faculty of Medicine, Faculty of Medicine in Hradec Králové
- Inflammatory bowel diseases in children2021 | Second Faculty of Medicine
- Telemedicine and inflammatory bowel disease - results of the IBD Assistant pilot project2020 | First Faculty of Medicine, Faculty of Physical Education and Sport
- First clinical experience with biosimilar adalimumab FKB327 in patients with inflammatory bowel disease2020 | First Faculty of Medicine
Loading network view...